Global Pharma Excipients Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Pharma Excipients Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Pharma Excipients Market Size Growth Rate by Product
  • 1.4.2 Polymers
  • 1.4.3 Alcohols
  • 1.4.4 Minerals
  • 1.4.5 Sugar
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global Pharma Excipients Market Size Growth Rate by End User
  • 1.5.2 Oral Solid Dosage Forms (OSDF)
  • 1.5.3 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pharma Excipients Market Size
  • 2.1.1 Global Pharma Excipients Revenue 2014-2025
  • 2.1.2 Global Pharma Excipients Sales 2014-2025
• 2.2 Pharma Excipients Growth Rate by Regions
  • 2.2.1 Global Pharma Excipients Sales by Regions
  • 2.2.2 Global Pharma Excipients Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Pharma Excipients Sales by Manufacturers
  • 3.1.1 Pharma Excipients Sales by Manufacturers
  • 3.1.2 Pharma Excipients Sales Market Share by Manufacturers
  • 3.1.3 Global Pharma Excipients Market Concentration Ratio (CR5 and HHI)
• 3.2 Pharma Excipients Revenue by Manufacturers
  • 3.2.1 Pharma Excipients Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pharma Excipients Revenue Share by Manufacturers (2014-2019)
• 3.3 Pharma Excipients Price by Manufacturers
• 3.4 Pharma Excipients Manufacturing Base Distribution, Product Types
  • 3.4.1 Pharma Excipients Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pharma Excipients Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pharma Excipients Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Pharma Excipients Sales by Product
• 4.2 Global Pharma Excipients Revenue by Product
• 4.3 Pharma Excipients Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Pharma Excipients Breakdown Data by End User

6 North America

• 6.1 North America Pharma Excipients by Countries
  • 6.1.1 North America Pharma Excipients Sales by Countries
  • 6.1.2 North America Pharma Excipients Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Pharma Excipients by Product
• 6.3 North America Pharma Excipients by End User

7 Europe

• 7.1 Europe Pharma Excipients by Countries
  • 7.1.1 Europe Pharma Excipients Sales by Countries
  • 7.1.2 Europe Pharma Excipients Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pharma Excipients by Product
• 7.3 Europe Pharma Excipients by End User

8 Asia Pacific

• 8.1 Asia Pacific Pharma Excipients by Countries
  • 8.1.1 Asia Pacific Pharma Excipients Sales by Countries
  • 8.1.2 Asia Pacific Pharma Excipients Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Pharma Excipients by Product
• 8.3 Asia Pacific Pharma Excipients by End User

9 Central & South America

• 9.1 Central & South America Pharma Excipients by Countries
  • 9.1.1 Central & South America Pharma Excipients Sales by Countries
  • 9.1.2 Central & South America Pharma Excipients Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Pharma Excipients by Product
• 9.3 Central & South America Pharma Excipients by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Pharma Excipients by Countries
  • 10.1.1 Middle East and Africa Pharma Excipients Sales by Countries
  • 10.1.2 Middle East and Africa Pharma Excipients Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Pharma Excipients by Product
• 10.3 Middle East and Africa Pharma Excipients by End User

11 Company Profiles

• 11.1 Archer Daniels Midland (ADM)
  • 11.1.1 Archer Daniels Midland (ADM) Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Archer Daniels Midland (ADM) Pharma Excipients Products Offered
  • 11.1.5 Archer Daniels Midland (ADM) Recent Development
• 11.2 BASF
  • 11.2.1 BASF Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 BASF Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 BASF Pharma Excipients Products Offered
  • 11.2.5 BASF Recent Development
• 11.3 DOW Chemical Company
  • 11.3.1 DOW Chemical Company Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 DOW Chemical Company Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 DOW Chemical Company Pharma Excipients Products Offered
  • 11.3.5 DOW Chemical Company Recent Development
• 11.4 Evonik
  • 11.4.1 Evonik Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Evonik Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Evonik Pharma Excipients Products Offered
  • 11.4.5 Evonik Recent Development
• 11.5 J.M. Huber Corporation
  • 11.5.1 J.M. Huber Corporation Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 J.M. Huber Corporation Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 J.M. Huber Corporation Pharma Excipients Products Offered
  • 11.5.5 J.M. Huber Corporation Recent Development
• 11.6 ABITEC Corporation
  • 11.6.1 ABITEC Corporation Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 ABITEC Corporation Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 ABITEC Corporation Pharma Excipients Products Offered
  • 11.6.5 ABITEC Corporation Recent Development
• 11.7 Cargill
  • 11.7.1 Cargill Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Cargill Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Cargill Pharma Excipients Products Offered
  • 11.7.5 Cargill Recent Development
• 11.8 Eastman Chemical Company
  • 11.8.1 Eastman Chemical Company Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Eastman Chemical Company Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Eastman Chemical Company Pharma Excipients Products Offered
  • 11.8.5 Eastman Chemical Company Recent Development
• 11.9 AkzoNobel
  • 11.9.1 AkzoNobel Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 AkzoNobel Pharma Excipients Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 AkzoNobel Pharma Excipients Products Offered
  • 11.9.5 AkzoNobel Recent Development

12 Future Forecast

• 12.1 Pharma Excipients Market Forecast by Regions
  • 12.1.1 Global Pharma Excipients Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Pharma Excipients Revenue Forecast by Regions 2019-2025
• 12.2 Pharma Excipients Market Forecast by Product
  • 12.2.1 Global Pharma Excipients Sales Forecast by Product 2019-2025
  • 12.2.2 Global Pharma Excipients Revenue Forecast by Product 2019-2025
• 12.3 Pharma Excipients Market Forecast by End User
• 12.4 North America Pharma Excipients Forecast
• 12.5 Europe Pharma Excipients Forecast
• 12.6 Asia Pacific Pharma Excipients Forecast
• 12.7 Central & South America Pharma Excipients Forecast
• 12.8 Middle East and Africa Pharma Excipients Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pharma Excipients Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details